Prosecution Insights
Last updated: October 27, 2026

Fatimata Sahra Diop, USPTO Patent Examiner

Listed by the USPTO as DIOP, FATIMATA SAHRA

Tech Center 3700 • Art Units: 3735 3783

This examiner grants 69% of resolved cases

Analysis

DIOP, FATIMATA SAHRA handles matters in Tech Center 3700 and Art Unit 3735. The profile records 86 resolved cases, a 68.6% allowance rate, and a median of 1428 days to allowance. The 38.0% interview lift is a significant feature of the available record, indicating that interviews are associated with improved allowance outcomes.

The listed companies are Bard Access Systems Inc., Massachusetts Institute of Technology, and CSP Technologies Inc. The leading firms are Brooks Kushman P.C., DINSMORE & SHOHL LLP, and DORSEY & WHITNEY LLP - Palo Alto. Because the case volume is limited, these figures should be used as directional guidance while giving particular attention to interview preparation and timing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.6%
Allow Rate
-1.4% vs TC avg
121
Total Applications
+38.0%
Interview Lift
1428
Avg Prosecution Days
Based on 86 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
25.9%
§102 Novelty
58.9%
§103 Obviousness
13.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18593431 Rapidly Insertable Central Catheters Including Catheter Assemblies and Methods Thereof Final Rejection Bard Access Systems, Inc.
18095968 Introducer Needles, Catheter Insertion Assemblies, and Methods Thereof Final Rejection Bard Access Systems, Inc.
18727623 AN IMPLANTABLE CLOSED-LOOP SYSTEM FOR MONITORING AND TREATMENT Non-Final OA Massachusetts Institute of Technology
17602148 DRUG DELIVERY DEVICE WITH SMART GRIP Non-Final OA AMGEN INC.
17610719 CARTRIDGE ADAPTER FOR DRUG DELIVERY DEVICE Non-Final OA Becton, Dickinson and Company
17665165 TECHNIQUES AND DEVICES FOR ADAPTATION OF MAXIMUM DRUG DELIVERY LIMITS Final Rejection Insulet Corporation
18022917 DRUG DELIVERY DEVICES WITH A MECHANICAL STOP Non-Final OA JANSSEN PHARMACEUTICA NV
18023566 DRUG COMBINATION KITS AND METHODS OF DRUG DELIVERY Final Rejection Massachusetts Eye and Ear Infirmary

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Fatimata Sahra Diop's allowance rate?

68.6% of resolved applications examined by Fatimata Sahra Diop were allowed (86 resolved cases), compared with 38.6% across Art Unit 3735 over the last five years.

Does an interview help with examiner Fatimata Sahra Diop?

This examiner's interview lift is +38.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Fatimata Sahra Diop take to allow a patent?

Applications allowed by Fatimata Sahra Diop took 1,428 days on average from filing to allowance.

Which art unit does examiner Fatimata Sahra Diop work in?

Fatimata Sahra Diop examines applications in Art Unit 3735 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month